Back to search

National and Kapodistrian University of Athens

Κλινικο-εργαστηριακή προσέγγιση σε παιδιατρικούς και εφηβικούς ασθενείς με Ιστιοκυττάρωση

Abstract

dc:description

Introduction Childhood histiocytoses, with Langerhans Cell Histiocytosis (LCH) being the most prevalent form, represent a diverse group of rare disorders distinguished by infiltration of multiple organs by myeloid lineage cells. The clinical presentation of histiocytoses spans a wide spectrum, ranging from benign, self-limiting lesions to aggressive malignancies and systemic inflammatory syndromes. Diagnosis is based on the combined evaluation of histological, clinical, and radiological data, and is particularly difficult and demanding due to overlapping histopathological and immunophenotypic features, as well as genetic complexity. Biopsy specimens exhibiting histiocytic infiltration frequently demonstrate somatic mutations in genes that activate the MAPK signaling pathway, with the BRAFV600E mutation being the most prevalent. A comprehensive diagnostic approach and molecular classification are required for accurate prognosis, which may range from spontaneous remission to severe, diffuse life-threatening disease. Targeted therapies with BRAF or MEK inhibitors have significantly contributed to the treatment of resistant forms of the disease. Methods In this thesis, clinical and laboratory data were recorded from 2012 to 2024, with emphasis on disease extent, age at diagnosis, sex, organ involvement, laboratory findings at diagnosis, response to initial treatment, risk of relapse, as well as the existence of an association between these parameters and the presence of the BRAFV600E mutation. Results During the study period, 47 children and adolescents were diagnosed with LCH and 9 children with other non-LCH histiocytoses. Of the 47 patients, twenty-seven (57.45%) were boys and twenty (42.55%) were girls. The median age at diagnosis was 6.20 years, and less than one third of individuals were under 324years old at the time of diagnosis. The majority, 43/47 (91.49%), were diagnosed with single-system LCH, with a higher proportion 35/47 (81.40%) being single-system and unifocal. More specifically, bone involvement occurred in 32/43 patients (74.42%), skin in 7/43 (16.28%), lymph nodes in 1/43 (2.33%), and other organs in 3/43 (6.98%). Regarding cases of multisystem involvement, 3/4 (75.00%) were identified as RO- and 1/4 (25.00%) as RO+. During the study period, 9 patients (5 girls/4 boys) were diagnosed with non-LCH histiocytoses. Seven children were diagnosed with juvenile xanthogranuloma, one with histiocytic sarcoma of the tibia, and one with Rosai-Dorfman disease of the CNS. The mean age at diagnosis among patients with non-LCH was 1.24 years. Among the patients with juvenile xanthogranuloma, 5/7 had localised skin disease, 1/7 localised liver disease, and 1/7 had a systemic form and therefore received intensive chemotherapy. In LCH patients who were tested for BRAFV600E , the mutation was detected in 57.14%. Age under 3 years and increased LDH levels at diagnosis were marginally associated with the presence of the BRAFV600E mutation. BRAFV600E mutation was present in all cases of patients with multisystem disease. Event-free survival (EFS) at 5 years was 80.0%, 91.7%, and 74.1% for negative, positive, and unknown BRAFV600E status respectively, without statistically significant differences. Conclusions This is the first study regarding the detection of the BRAFV600E mutation in children and adolescents in Greece with Langerhans Cell Histiocytosis. Although statistical significance was not established, this group suggests an association between the presence of the BRAFV600E mutation, more aggressive disease, and younger age. Further studies are required to confirm these observations and to evaluate the usefulness of assessing BRAF as a tool for guiding therapeutic choices.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tsipou, Haroula
  • Τσίπου, Χαρούλα

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/61640

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tsipou, Haroula; Τσίπου, Χαρούλα. Κλινικο-εργαστηριακή προσέγγιση σε παιδιατρικούς και εφηβικούς ασθενείς με Ιστιοκυττάρωση. National and Kapodistrian University of Athens, 2026. http://hdl.handle.net/10442/hedi/61640